Ind-Swift Laboratories Ltd.

Financial

	Ind-Swift Lab.	Sakar Healthcare	Venus Remedies
Operational Metrics
Pharmaceutical Sector
Total reactor capacity	700.0 kL	n/a	n/a
DMF Filingsby API	474.0 .	n/a	n/a
R&D as a % of Total Sales	3.01 %	n/a	n/a
Financials
5 yr Average ROE	9.6 %	9.28 %	6.64 %
5yr average Equity Multiplier	2.49	1.75	1.46
5yr Average Asset Turnover Ratio	0.67	0.5	0.89
5yr Avg Net Profit Margin	6.7 %	10.38 %	4.93 %
Price to Book	0.65	2.41	1.09
P/E	2.72	39.29	13.5
5yr Avg Cash Conversion Cycle	76.78 Days	-14.29 Days	72.13 Days
Inventory Days	126.74 Days	46.75 Days	93.66 Days
Days Receivable	95.44 Days	51.16 Days	47.69 Days
Days Payable	94.9 Days	103.34 Days	52.51 Days
5yr Average Interest Coverage Ratio	3.49	5.43	176.34
5yr Avg ROCE	12.63 %	10.08 %	6.96 %
5yr Avg Operating Profit Margin	19.31 %	24.06 %	10.58 %
5 yr average Debt to Equity	1.22	0.47	0.22
5yr CAGR Net Profit	n/a	3.94 %	n/a
5yr Average Return on Assets	7.66 %	5.37 %	5.11 %
Shareholdings
Promoter Holding	40.94 %	53.58 %	41.76 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.06 %	-13.96 %	0.95 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Ind-Swift Lab.	Sakar Healthcare	Venus Remedies
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Loan Licensing 0 Export 0 CDMO 0	Product Wise Break-Up Export 73.0 CDMO 22.0 Pharmaceutical 0 Loan Licensing 5.0	Product Wise Break-Up Export 0 CDMO 0 Pharmaceutical 0 Loan Licensing 0 Others 100
Location Wise Break-Up	Location Wise Break-Up India 21.75 International 0 Domestic 0 Others 78.25	Location Wise Break-Up Domestic 38.1 India 0 International 61.9	Location Wise Break-Up Domestic 0 India 33.0 International 0 Others 67.0
Operating Profit Break-Up	Operating Profit Break-Up India 18.87 Others 81.13	-	-
Asset Break-Up	Asset Break-Up India 67.55 Others 32.45	-	-